DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18393
| null |
EP-217609
|
894494-99-6
|
R6464792NG
|
EP217609
|
QIBHGITUGYXJDF-UDLCEBFESA-N
|
DB18394
| null |
Iodine I-124 Evuzamitide
|
2420475-06-3
|
9DR4VH0DJP
|
124I-p5+14 | Evuzamitide Iodine I-124 | Glycylglycylglycyl-3-(iodo-124I)-L-tyrosyl-L-seryl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L | Iodine (124i) evuzamitide | iodine (¹²⁴I) evuzamitide | Iodine (I-124) evuzamitide | IODINE I 124 EVUZAMITIDE | L-Glutamine, glycylglycylglycyl-ar-(iodo-124I)-L-tyrosyl-L-seryl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-
| null |
DB18395
| null |
LAVA-051
| null | null | null | null |
DB18396
| null |
IFx-Hu2.0
| null | null |
IFx-Hu20 | Immunotherapeutic vaccine consisting of pAc/emm55, a plasmid DNA (pDNA), which codes for a modified immunogenic, streptococcal Emm55 protein, complexed with in vivo-jetPEI® polymer-based reagent linear polyethylenimine)
| null |
DB18397
| null |
RGX-202
| null | null | null | null |
DB18398
| null |
Calmangafodipir
|
1401243-67-1
|
N0JZU0WGU5
|
Calcium,n,n'-1,2-ethanediylbis(n-((3-hydroxy-2-methyl-5-((phosphonooxy)methyl)-4-pyridinyl)methyl)glycine) manganese complexes trisodium trihydrogen manganate | Calmangafodipir (ca4mn(dpdp)5) | Pledox | Tetracalcium monomanganese penta(dipyridoxyl diphosphate)
|
QAOJLUYEMFXJGX-UHFFFAOYSA-D
|
DB18399
| null |
Cardiotrophin 1
|
1422101-11-8
|
AJ7U77BR8I
|
Cardiotrophin-1 | CT-1 | Protein cardiotrophin (human isoform 1)
| null |
DB18400
| null |
Cemsidomide
|
2504235-67-8
|
D86MF5H9WJ
|
(3s)-3-(6-((4-(morpholin-4-ylmethyl)phenyl)methyl)-2-oxobenzo(cd)indol-1-yl)piperidine-2,6-dione | 2,6-piperidinedione, 3-(6-((4-(4-morpholinylmethyl)phenyl)methyl)-2-oxobenz(cd)indol-1(2h)-yl)-, (3s)-
|
MUKCJOOKCZSQNW-DEOSSOPVSA-N
|
DB18401
| null |
KP1237
| null | null | null | null |
DB18402
| null |
Cinrebafusp alfa
|
2218515-90-1
|
21Z359Z1CV
|
(S228>P,F234>A,L235>A) IMMUNOGLOBULIN G4-KAPPA (CHIMERIC HUMAN-MUS MUSCULUS, ANTI-(RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2, ERBB2, HER2)) FUSED ON BOTH HEAVY CHAINS (1-447, 1''-447'') VIA A (G4S)3 LINKER (448-462, 448''-462'') TO A CD137 (TUMOR NECROSIS | Fus: mab humanized (igg4) s228p, f234a, l235a anti p04626 (erbb2_human)rprot p80188 (ngal_human) anti q07011 (tnr9_human) (prs343) | IMMUNOGLOBULIN G4 (228-PROLINE, 234-ALANINE, 235-ALANINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL PRS-343 .GAMMA.4-CHAIN) FUSION PROTEIN PEPTIDE (SYNTHETIC 15-AMINO ACID LINKER) FUSION PROTEIN WITH LIPOCALIN 2 (HUMAN MU
| null |
DB18403
| null |
Zilovertamab
|
2485779-13-1
|
FEH7RQ7B3J
|
Cirmtuzumab | Immunoglobulin g1, anti-(human receptor tyrosine kinase ror-1) (human-mus musculus monoclonal uc-961 .gamma.1-chain), disulfide with human-mus musculus monoclonal uc-961 .kappa.-chain, dimer
| null |
DB18404
| null |
Cotsiranib
| null | null |
STP705 (small interfering RNA (siRNA) therapeutic directed against transforming growth factor-beta 1 (TGF-beta 1) and cyclo-oxygenase-2 (COX-2))
| null |
DB18405
| null |
Crisdesalazine
|
927685-43-6
|
11VWK61J69
|
2-hydroxy-5-((2-(4-(trifluoromethyl)phenyl)ethyl)amino)benzoic acid | Benzoic acid, 2-hydroxy-5-((2-(4-(trifluoromethyl)phenyl)ethyl)amino)-
|
UTMVACIBQLDZLP-UHFFFAOYSA-N
|
DB18406
| null |
Secalciferol
|
55721-11-4
|
460029IUDA
|
(5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-3b,24,25-triol | 2,3-heptanediol, 2-methyl-6-((1r,3as,4e,7ar)-octahydro-4-((2z)-2-((5s)-5-hydroxy-2-methylenecyclohexylidene)ethylidene)-7a-methyl-1h-inden-1-yl)-, (3r,6r)- | 24(R),25-(OH)2D3 | Osteo d
|
FCKJYANJHNLEEP-XRWYNYHCSA-N
|
DB18407
| null |
ABBV-CLS-7262
| null |
BN9FN5629V
|
Sodium ({(2S)-1,4-bis[2-(4-chloro-3- fluorophenoxy)acetamido]bicyclo[2.2.2]octan-2- yl}oxy)methyl hydrogen phosphate - 2-amino-2- (hydroxymethyl)propane-1,3-diol (1/1/1)
|
RQOVFRFZOGXABE-IPMISBIPSA-M
|
DB18408
| null |
BR-007
|
2409546-40-1
|
87VER89275
|
(1-hydroxy-4-(((2-((4-(2-(pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethoxy)carbonyl)amino)butane-1,1-diyl)bis(hydrogen phosphonate)
|
AKZVACKATXEQQW-UHFFFAOYSA-N
|
DB18409
| null |
Fobrepodacin
|
1384984-31-9
|
1NL76YUU6E
|
N-ethyl-n'-(6-fluoro-5-(2-(1-methyl-1-(phosphonooxy)ethyl)-5-pyrimidinyl)-7-((2r)-tetrahydro-2-furanyl)-1h-benzimidazol-2-yl)urea | SPR-720 FREE ACID | Urea, n-ethyl-n'-(6-fluoro-5-(2-(1-methyl-1-(phosphonooxy)ethyl)-5-pyrimidinyl)-7-((2r)-tetrahydro-2-furanyl)-1h-benzimidazol-2-yl)- | Vxc-486 phosphate
|
COTQDURISRILOR-CQSZACIVSA-N
|
DB18410
| null |
Acazicolcept
|
2270247-50-0
|
W507556HV0
|
1-122-INDUCIBLE COSTIMULATORY LIGAND PROTEIN (52-HISTIDINE,57-TYROSINE,100-ARGININE) (HUMAN) FUSION PROTEIN WITH SYNTHETIC PEPTIDE LINKER (GGGGSGGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C REGION VARIANT C-TERMINAL FRAGMENT), DIMER | Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways | HUMAN INDUCIBLE T-CELL CO-STIMULATOR LIGAND (ICOS LIGAND) N-TERMINAL FRAGMENT (1-122) (VARIANT (N52>H, N57>Y, Q100>R), FUSED VIA PEPTIDYL LINKER 123GGGGSGGGGS132 TO A HUMAN IMMUNOGLOBULIN G1 FC FRAGMENT (133-363) VARIANT (C137>S, L151>A, L152>E, G154>A,
| null |
DB18411
| null |
Anbenitamab
|
2367012-88-0
|
RHS90QRF9E
|
ANTI-HER2 BSAB KN026 | FC-fusion bispecific antibody targeting extracellular domains II and IV of HER 2 and FC-fusion bispecific IgG1 antibody inhibiting PD-L1 and CTLA-4 | IMMUNOGLOBULIN G1 (369-SERINE,371-ALANINE,408-LYSINE,410-VALINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 DOMAIN IV)(HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .KAPPA.-CHAIN
| null |
DB18412
| null |
AD-214
| null | null |
Fc-fusion protein comprised of an anti-CXCR4 i-body tethered at its C-terminus to constant domains 2 and 3 of the Fc region of a mutated human IgG1
| null |
DB18413
| null |
KUR-113
| null | null |
Fibrin-based agent containing a N-terminally modified parathyroid hormone fragment TGplPTH1-34 | Fibrin-PTH
| null |
DB18414
| null |
CAM-101
| null | null |
fibrinogen-depleted human platelet lysate
| null |
DB18415
| null |
rAAV9-hNAGLU
| null | null | null | null |
DB18416
| null |
AVB-101
| null | null | null | null |
DB18417
| null |
PF-05230907
| null |
W1DT53SAN0
|
FXA VARIANT I16L | RECOMBINANT FACTOR XA VARIANT FXAI16L
| null |
DB18418
| null |
BIIB115
| null | null | null | null |
DB18419
| null |
FLT201
| null | null | null | null |
DB18420
| null |
FLT190
| null | null | null | null |
DB18421
| null |
tgAAG-76
| null | null |
rAAV2/2.hRPE65p.hRPE65 | tgAAG 76 | tgAAG76
| null |
DB18422
| null |
NFS-02
| null | null |
rAAV2-ND1 | recombinant adeno-associated virus serotype 2 containing human mitochondrial ND1 codon optimized gene (rAAV2-ND1)
| null |
DB18423
| null |
ASC-618
| null | null | null | null |
DB18424
| null |
ZVS101e
| null | null | null | null |
DB18425
| null |
RBIO-101
| null | null |
AAV.CYP4V2 | recombinant adeno-associated virus vector encoding human CYP4V2 protein
| null |
DB18426
| null |
Denecimig
|
2488745-86-2
|
EUV85RR8DJ
|
Immunoglobulin G4 [230-proline,de-449-lysine], anti-(human blood-coagulation factor IX) (human clone 0365-0001-9985 γ4-chain), disulfide with human clone 0365-0001-9985 κ-chain, (228.fwdarw.226′),(231.fwdarw.229′)-bis(disulfide) with anti-(human bl
| null |
DB18427
| null |
Cendakimab
| null |
O8R9U9ZUVN
|
HUMANIZED ANTI-HUMAN IL-13 MONOCLONAL ANTIBODY | IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL-13 (INTERLEUKIN 13, IL-13)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV2-5*08 (80.6%) -(IGHD) -IGHJ4*01 (100%)) (10.7.15) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G | IMMUNOGLOBULIN G1(240-ALANINE, 241-ALANINE), ANTI-(HUMAN INTERLEUKIN 13) (HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .GAMMA.-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
| null |
DB18428
| null |
RC118
| null | null |
Recombinant humanized anti-MSLN monoclonal antibody- monomethyl auristatin E conjugate
| null |
DB18429
| null |
Dazukibart
|
2639474-65-8
|
K2Q0JXS9B4
|
Immunoglobulin G1 [236-alanine,237-alanine,239-alanine,de-C-terminal-lysine], anti-(human interferon β) (human-Mus musculus monoclonal PF-06823859 γ1-chain), disulfide with human-Mus musculus monoclonal PF-06823859 κ-chain, dimer | Mab humanized (igg1) anti p01574 (ifnb_human) (pf06823859) | Recombinant humanized monoclonal antibody (immunoglobulin gamma-1 with kappa light chains, IgG1kappa) directed against human soluble cytokine interferon beta.
| null |
DB18430
| null |
Progranulin
| null |
T2LF50ID3Y
|
Acrogranin | Glycoprotein 88
| null |
DB18431
| null |
Prolactin G129R
| null |
Y88638Q24R
|
Prolactin receptor antagonist (Prolactin G129R) | Prolanta
| null |
DB18432
| null |
AGTC-401
| null | null |
AAV-CNB3 | AAV-PR1.7-hCNGBco vector | AAV2tYF-PR1.7-hCNGB3co | AAV9-PR1.7-hCNGB3co | ACHM CNGB3 | rAAV2-hCNGB3 | rAAV2tYF-PR1.7-hCNGB3
| null |
DB18433
| null |
AGTC-402
| null | null |
ACHM A3 | ACHM CNGA3 | rAAV2tYF-PR.1-hCNGA3 | recombinant Adeno-associated virus vector expressing CNGA3
| null |
DB18434
| null |
SEL-302
| null | null | null | null |
DB18435
| null |
TG-1042
| null | null |
Ad-IFNγ | Adenovirus interferon gamma
| null |
DB18436
| null |
GL-0719
| null | null | null | null |
DB18437
| null |
RO7200220
| null | null | null | null |
DB18438
| null |
Recombinant surfactant protein D
| null | null |
Recombinant surfactant SP-D | rfhSP-D
| null |
DB18439
| null |
SCIB1
| null | null | null | null |
DB18440
| null |
Vurolenatide
|
2434640-83-0
|
GT0UZY3RPJ
|
GLP-1-XTEN | L-HISTIDYLGLYCYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-LEUCYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-GLUTAMYL-L-.ALPHA.-GLUTAMYL-L-ALANYL-L-VALYL-L-ARGINYL-L-LEUCYL-L-PHE | XTEN-GLP1
| null |
DB18441
| null |
Maplirpacept
| null |
44D51T6SZH
|
1-118-Signal regulatory protein α (human) fusion protein with immunoglobulin G4 [128-proline] (human γ4-chain C region C-terminal fragment), dimer | SIRPA-IGG4-FC FUSION PROTEIN TTI-622
| null |
DB18442
| null |
ABSK-091
|
1035270-39-3
| null |
Benzamide, n-(5-(2-(3,5-dimethoxyphenyl)ethyl)-1h-pyrazol-3-yl)-4-((3r,5s)-3,5-dimethyl-1-piperazinyl)-, rel-
|
VRQMAABPASPXMW-HDICACEKSA-N
|
DB18443
| null |
CFT-8634
|
2704617-96-7
|
AW8PEP3VZ3
|
2,6-PIPERIDINEDIONE, 3-((4-(4-((4S)-1-((4-(1,6-DIHYDRO-1,4,5-TRIMETHYL-6-OXO-3-PYRIDINYL)-2,6-DIMETHOXYPHENYL)METHYL)-3,3-DIFLUORO-4-PIPERIDINYL)-1-PIPERAZINYL)-3-FLUOROPHENYL)AMINO)-, (3S)-
|
GNRGNRCQXHMQQV-ZQAZVOLISA-N
|
DB18444
| null |
Bexotegrast
|
2376257-44-0
|
QCV154PFT4
|
(2S)-4-(2-METHOXYETHYL-(4-(5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)BUTYL)AMINO)-2-(QUINAZOLIN-4-YLAMINO)BUTANOIC ACID | (S)-4-[(2-Methoxyethyl)[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-[(quinazolin-4-yl)amino]butanoic acid | Butanoic acid, 4-[(2-methoxyethyl)[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butyl]amino]-2-(4-quinazolinylamino)-, (2S)-
|
CWOFQJBATWQSHL-DEOSSOPVSA-N
|
DB18445
| null |
CC-90001
|
1403859-14-2
|
JD5ZWE631K
|
2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-5-PYRIMIDINECARBOXAMIDE | 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE | 5-PYRIMIDINECARBOXAMIDE, 2-((1,1-DIMETHYLETHYL)AMINO)-4-(((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYL)AMINO)-
|
QBBRJRLJWXRSHQ-CKYFFXLPSA-N
|
DB18446
| null |
RAPA-201
| null | null |
Autologous rapamycin-resistant Th1/Tc1 cells | Rapamycin-resistant autologous Th1/Tc1 T-cells
| null |
DB18447
| null |
PB-722
| null | null | null | null |
DB18448
| null |
GDX012
| null | null |
Allogeneic enriched variable delta 1 gamma delta T-cells | Allogeneic Vδ1+ γδ T cells | GDX012
| null |
DB18449
| null |
Mycobacterium vaccae
| null |
I639ME27W5
|
Mycobacterium vaccae | Mycobacterium vaccae whole
| null |
DB18450
| null |
Atelocollagen
| null | null |
Purified bovine type V collagen
| null |
DB18451
| null |
Col-Treg
| null | null |
Purified autologous type 1 regulatory T lymphocytes specific for human type II collagen
| null |
DB18452
| null |
AVB-001
| null | null | null | null |
DB18453
| null |
EXT608
| null | null | null | null |
DB18454
| null |
AVID-200
|
2269485-28-9
|
6EX05GL2VK
|
Tgf-.beta. ligand trap comprised of tgf-.beta. receptor ectodomains fused to a human fc domain (avid-200) | Tgf-beta 1/3 inhibitor avid200 | Tgfbeta receptor ectodomain-igg fc fusion protein avid200
| null |
DB18455
| null |
AVX-470
| null | null | null | null |
DB18456
| null |
Ispectamab debotansine
|
2413386-21-5
|
WY39ZX6NZU
| null | null |
DB18457
| null |
Zilovertamab vedotin
|
2376463-48-6
|
IZY9ZSI6FI
| null | null |
DB18458
| null |
IMMU-114
| null | null | null | null |
DB18459
| null |
NVD-001
| null | null |
Autologous osteogenic stem cells | NVD-001
| null |
DB18460
| null |
Eftansomatropin alfa
|
1905448-17-0
|
1CPV8ZQB38
|
Eftansomatropin alfa | Somatotropin (human) fusion protein with immunoglobulin (synthetic hybrid fc fragment hyfc)
| null |
DB18461
| null |
IBP-1118
|
2483-17-2
|
H694N9A9AP
|
Arginyl-glutamine dipeptide
| null |
DB18462
| null |
Saltikva
| null | null | null | null |
DB18463
| null |
Narmafotinib
|
1393653-34-3
|
16T7U12J7U
|
2-(2-(2-((2-methoxy-4-(1-methyl-4-piperidinyl)phenyl)amino)-5-(trifluoromethyl)-4-pyrimidinyl)ethyl)benzeneacetamide | Benzeneacetamide, 2-(2-(2-((2-methoxy-4-(1-methyl-4-piperidinyl)phenyl)amino)-5-(trifluoromethyl)-4-pyrimidinyl)ethyl)-
|
AWJVIOYPZZZYAX-UHFFFAOYSA-N
|
DB18464
| null |
Esuberaprost
|
94132-88-4
|
1JSN1I7582
|
(+)-4-((1r,2r,3as,8bs)-2-hydroxy-1-((1e,3s,4s)-3-hydroxy-4-methyl-oct-1-en-6-yn-1-yl)-2,3,3a,8b-tetrahydro-1h-cyclopenta(b)(1)benzofuran-5-yl)butanoic acid | 1h-cyclopenta(b)benzofuran-5-butanoic acid, 2,3,3a,8b-tetrahydro-2-hydroxy-1-((1e,3s,4s)-3-hydroxy-4-methyl-1-octen-6-ynyl)-, (1r,2r,3as,8bs)- | Aps-314d free acid | Beraprost, (+)-
|
CTPOHARTNNSRSR-NOQAJONNSA-N
|
DB18465
| null |
KIO-301
|
1224953-72-3
|
57HBP7XKS9
| null |
XJSTVCBWJAUVAR-UHFFFAOYSA-O
|
DB18466
| null |
NMD-670
|
2354321-33-6
|
U7PP8PY4XB
|
bromophenoxyazole propanoic acid
| null |
DB18467
| null |
HT-KIT
| null | null | null | null |
DB18468
| null |
Gildeuretinol
|
118139-36-9
|
JN7W3M3OI7
|
C20-D3-retinyl acetate | VITAMIN A ACETATE C20-D3
| null |
DB18469
| null |
VG161
| null | null |
Recombinant human IL12/15-PDL1B HSV-1 oncolytic virus Injection
| null |
DB18470
| null |
UV1
| null | null | null | null |
DB18471
| null |
PT886
| null | null | null | null |
DB18472
| null |
PT217
| null | null | null | null |
DB18473
| null |
ASP-2138
| null | null | null | null |
DB18474
| null |
Emerfetamab
|
2250261-27-7
|
HOG226RYH1
| null | null |
DB18475
| null |
ISB 1442
| null | null | null | null |
DB18476
| null |
VBI-1901
| null | null | null | null |
DB18477
| null |
Heat stable ricin vaccine
| null | null | null | null |
DB18478
| null |
Rodatristat
|
1673568-73-4
|
91D8378G2V
|
(3s)-8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)-4-pyrimidinyl)-2,8-diazaspiro(4.5)decane-3-carboxylic acid | (3s)-8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-2,8-diazaspiro(4.5)decane-3-carboxylic acid | 2,8-diazaspiro(4.5)decane-3-carboxylic acid, 8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)-4-pyrimidinyl)-, (3s)-
|
ZNSPHKJFQDEABI-NZQKXSOJSA-N
|
DB18479
| null |
Rodatristat ethyl
|
1673571-51-1
|
507FY6OL37
|
2,8-diazaspiro(4.5)decane-3-carboxylic acid, 8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)-4-pyrimidinyl)-, ethyl ester, (3s)- | Ethyl (3s)-8-(2-amino-6-((1r)-1-(5-chloro(1,1'-biphenyl)-2-yl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)-2,8-diazaspiro(4.5)decane-3-carboxylate
|
TZSZZENYCISATO-WIOPSUGQSA-N
|
DB18480
| null |
Roseburia hominis
| null |
M881HBT4WO
| null | null |
DB18481
| null |
Avasopasem
| null |
HP219O4H4V
|
(4AS,13AS,17AS,21AS)-1,2,3,4,4A,5,6,12,13,13A,14,15,16,17,17A,18,19,20,21,21A-EICOSAHYDRO-11,7-NITRILO-7H-DIBENZO(B,H)(1,4,7,10)TETRAAZACYCLOHEPTADECINE
|
MTQZSJFDXWEENV-TUFLPTIASA-N
|
DB18482
| null |
MALP-2
|
250718-44-6
|
DZX5IUA94D
|
L-lysine, s-((2r)-2,3-bis((1-oxohexadecyl)oxy)propyl)-l-cysteinylglycyl-l-asparaginyl-l-asparaginyl-l-.alpha.-aspartyl-l-.alpha.-glutamyl-l-seryl-l-asparaginyl-l-isoleucyl-l-seryl-l-phenylalanyl-l-lysyl-l-.alpha.-glutamyl- | Macrophage-activating lipopeptide-2 | S-(2,3-bispalmitoyloxy-(2r)-propyl)-cysteinly-gnndesnisfkek | S-[2,3-bispalmitoyloxy-(2R)-propyl]-cysteinly-GNNDESNISFKEK
|
DMWMUMWKGKGSNW-OPMCLZTFSA-N
|
DB18483
| null |
Heparan-N-sulfatase (human, recombinant)
| null | null |
Recombinant human heparan-N-sulfatase | rhHNS
| null |
DB18484
| null |
DOTMP SM-153
|
633308-21-1
|
S5NN2E9ZKF
|
153sm-1,4,7,10-tetraazacyclododecane-1,4,7,10- tetramethylene-phosphonic acid | 153sm-dotmp | Cyclosam | Samarate(5-)-153sm, ((((1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-.kappa.n1,.kappa.n4,.kappa.n7,.kappa.n10)tetrakis(methylene))tetrakis(phosphonato-.kappa.o))(8-))-, pentahydrogen | Samarium-153 dotmp
|
LNBUCNBAQQFTBL-GJNDDOAHSA-K
|
DB18485
| null |
ALT-P1
| null | null |
Recombinant human growth hormone fused to alpha1-antitrypsin variant
| null |
DB18486
| null |
EI-1071
| null | null | null | null |
DB18487
| null |
KT-253
| null | null | null | null |
DB18488
| null |
DMP-777
|
157341-41-8
|
3Q0469283P
|
1-AZETIDINECARBOXAMIDE, N-((1R)-1-(1,3-BENZODIOXOL-5-YL)BUTYL)-3,3-DIETHYL-2-(4-((4-METHYL-1-PIPERAZINYL)CARBONYL)PHENOXY)-4-OXO-, (2S)-
|
ZSDCIRYNTCVTMF-GIGWZHCTSA-N
|
DB18489
| null |
Elenestinib
|
2505078-08-8
|
6FBM4CP6RK
|
(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol | 1H-Pyrazole-1-ethanol, 4-[4-[4-[5-[(1S)-1-amino-1-(4-fluorophenyl)ethyl]-2-pyrimidinyl]-1-piperazinyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]- | 2-{4-[4-(4-{5-[(1S)-1-amino-1-(4- fluorophenyl)ethyl]pyrimidin-2-yl}piperazin-1- yl)pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1H-pyrazol-1- yl}ethan-1-ol | 4-[4-[4-[5-[(1S)-1-Amino-1-(4-fluorophenyl)ethyl]-2-pyrimidinyl]-1-piperazinyl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]-1H-pyrazole-1-ethanol
|
IPMARPMXSFFZFG-MHZLTWQESA-N
|
DB18490
| null |
Aficamten
|
2364554-48-1
|
B1I77MH6K1
|
1h-pyrazole-4-carboxamide, n-((1r)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl- | N-((1r)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)- 1-methyl-1h-pyrazole-4-carboxamide
|
IOVAZWDIRCRMTM-OAHLLOKOSA-N
|
DB18491
| null |
LTI-03
|
1504575-10-3
|
JE7G34JYW4
|
L-threonine, l-phenylalanyl-l-threonyl-l-threonyl-l-phenylalanyl-l-threonyl-l-valyl- | Phe-thr-thr-phe-thr-val-thr
| null |
DB18492
| null |
CPO-107
| null | null | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.